Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Free Newsletter Sign Up

Abbott Wants Premature Infant Formula Suits Sent to Connecticut

Jan. 20, 2022, 5:17 PM

Abbott Laboratories wants the U.S. Judicial Panel on Multidistrict Litigation to create a single proceeding in Connecticut for suits alleging its formula products caused injury or death in premature infants.

Parents allege the Abbott products, administered under the direction of specialists treating babies in neonatal intensive care units, caused necrotizing enterocolitis.

NEC is an umbrella term for an inflammatory disease of the gastrointestinal tract occurring in up to 8% of infants in NICUs, and is a leading cause of death among premature infants weighing less than 3.3 pounds, Abbott’s filing said.

Abbott denied the parents’ allegations, saying NEC has many ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.